Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
79.02 USD | +0.18% | -1.47% | +39.16% |
05-31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
05-10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.16% | 1.77B | |
+6.30% | 217B | |
+11.74% | 190B | |
+18.51% | 143B | |
+29.79% | 111B | |
+0.65% | 64.59B | |
+14.24% | 52.36B | |
+2.06% | 48.45B | |
-5.04% | 38.03B | |
-0.89% | 35.6B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating